Agrarian diet and diseases of affluence - Do evolutionary novel dietary lectins cause leptin resistance?

BMC Endocrine Disorders

Volumn 5, Issue , 2005, Pages

  Jönsson, Tommy ^a   Olsson, Stefan ^b   Ahrén, Bo ^a   Bøg Hansen, Thorkild C ^c   Dole, Anita ^c   Lindeberg, Staffan ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LECTIN; LEPTIN; LEPTIN RECEPTOR;

ADAPTATION; ARTICLE; CARDIOVASCULAR DISEASE; CEREAL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL FACTOR; INCIDENCE; INSULIN SENSITIVITY; METABOLISM; MORTALITY; OBESITY; PROTEIN BINDING; RECEPTOR BINDING; RISK FACTOR; SWINE;

EID: 29244490643     PISSN: 14726823     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-5-10     Document Type: Article

References (99)

1. McKeown T: The origins of human disease. Basil Blackwell; 1988.
2. Trowell HC, Burkitt DP (Eds.): Western diseases: their emergence and prevention. London: Edward Arnold; 1981.
3. Temple NJ, Burkitt DP: Western diseases : their dietary prevention and reversibility. Totowa, N.J.: Humana Press; 1994.
4. Semaw S, Rogers MJ, Quade J, Renne PR, Butler RF, Dominguez-Rodrigo M, Stout D, Hart WS, Pickering T, Simpson SW: 2.6-Million-year-old stone tools and associated bones from OGS-6 and OGS-7, Gona, Afar, Ethiopia. J Hum Evol 2003, 45:169-177.
5. Lindeberg S, Cordain L, Eaton B: Biological and Clinical Potential of a Palaeolithic Diet. Journal of Nutritional & Environmental Medicine 2003, 13:149-160.
6. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21:1414-1431.
7. Van Dam RM: The epidemiology of lifestyle and risk for type 2 diabetes. Eur J Epidemiol 2003, 18:1115-1125.
8. Walker AR, Walker BF, Segal I: Some puzzling situations in the onset, occurrence and future of coronary heart disease in developed and developing populations, particularly such in sub-Saharan Africa. J R Soc Health 2004, 124:40-46.
9. Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB: Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 2001, 161:1542-1548.
10. Feigin VL, Lawes CM, Bennett DA, Anderson CS: Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003, 2:43-53.
11. Hu FB: Protein, body weight, and cardiovascular health. Am J Clin Nutr 2005, 82:242S-247S.
12. Kromhout D: Epidemiology of cardiovascular diseases in Europe. Public Health Nutr 2001, 4:441-457.
13. Pavan L, Casiglia E, Braga LM, Winnicki M, Puato M, Pauletto P, Pessina AC: Effects of a traditional lifestyle on the cardiovascular risk profile: the Amondava population of the Brazilian Amazon. Comparison with matched African, Italian and Polish populations. J Hypertens 1999, 17:749-756.
14. Lindeberg S: Apparent absence of cerebrocardiovascular disease in Melanesians. Risk factors and nutritional considerations - the Kitava Study. PhD Thesis. University of Lund, 1994.
15. Lindeberg S: Stroke in Papua New Guinea. Lancet Neurol 2003, 2:273; discussion 273.
16. Dobzhansky T: Nothing in Biology Makes Sense Except in the Light of Evolution. American Biology Teacher 1973, 35:125-129.
17. Willis KJ, McElwain JC: The evolution of plants. Oxford: Oxford University Press; 2002.
18. Sargis EJ: Paleontology. Primate origins nailed. Science 2002, 298:1564-1565.
19. Jones S, Martin R, Pilbeam D (Eds.): The Cambridge encyclopedia of human evolution. Cambridge: Cambridge University Press; 1992.
20. Wood B, Brooks A: Human evolution. We are what we ate. Nature 1999, 400:219-220.
21. Preuschoft H: Mechanisms for the acquisition of habitual bipedality: are there biomechanical reasons for the acquisition of upright bipedal posture? J Anat 2004, 204:363-384.
22. Pickford M: Palaeoenvironments and hominoid evolution. Z Morphol Anthropol 2002, 83:337-348.
23. Bramble DM, Lieberman DE: Endurance running and the evolution of Homo. Nature 2004, 432:345-352.
24. Milton K: Primate Diets and Gut Morphology: Implications for Hominid Evolution. In Food and evolution : toward a theory of human food habits : 94th; Philadelphia. Edited by Ross Eric B, Harris M, Wenner-Gren Foundation for Anthropological R. Temple University Press; 1987: pp 93-115.
25. Richards MP: A brief review of the archaeological evidence for Palaeolithic and Neolithic subsistence. Eur J Clin Nutr 2002, 56:16 p following 1262.
26. McDougall I, Brown FH, Fleagle JG: Stratigraphic placement and age of modern humans from Kibish, Ethiopia. Nature 2005, 433:733-736.
27. Ingman M, Kaessmann H, Paabo S, Gyllensten U: Mitochondrial genome variation and the origin of modern humans. Nature 2000, 408:708-713.
28. Kuhn SL, Stiner MC: The Antiquity of Hunter-gatherers. In Hunter-gatherers : an interdisciplinary perspective. Edited by Panter-Brick C, Rowley-Conwy P, Layton R. Cambridge: Cambridge University Press; 2001: pp 99-142: The Biosocial Society symposium series].
29. Cronin CC, Shanahan F: Why is celiac disease so common in Ireland? Perspect Biol Med 2001, 44:342-352.
30. Rostami K, Malekzadeh R, Shahbazkhani B, Akbari MR, Catassi C: Coeliac disease in Middle Eastern countries: a challenge for the evolutionary history of this complex disorder? Dig Liver Dis 2004, 36:694-697.
31. Freeman S, Herron JC: Evolutionary analysis. 3rd ed. edn: Upper Saddle River; 2004.
32. Veniant MM, LeBel CP: Leptin: from animals to humans. Curr Pharm Des 2003, 9:811-818.
33. El-Haschimi K, Lehnert H: Leptin resistance - or why leptin fails to work in obesity. Exp Clin Endocrinol Diabetes 2003, 111:2-7.
34. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS: Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 2000, 105:1827-1832.
35. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A 1997, 94:8878-8883.
36. Jequier E: Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002, 967:379-388.
37. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995, 1:1311-1314.
38. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, et al.: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995, 1:1155-1161.
39. Unger RH: Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine. Biochimie 2005, 87:57-64.
40. Trayhurn P: Leptin--a critical body weight signal and a "master" hormone? Sci STKE 2003, 2003:PE7.
41. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL: Serum immunoreactive-leptin concentrations in normal-weight and obese humans [see comments]. N Engl J Med 1996, 334:292-295.
42. Jameson JL: Molecular mechanisms of end-organ resistance. Growth Horm IGF Res 2004, 14 Suppl A:S45-50.
43. Gaucher EA, Miyamoto MM, Benner SA: Evolutionary, structural and biochemical evidence for a new interaction site of the leptin obesity protein. Genetics 2003, 163:1549-1553.
44. Doyon C, Drouin G, Trudean VL, Moon TW: Molecular evolution of leptin. Gen Comp Endocrinol 2001, 124:188-198.
45. Hoyo Josep D, Arlott N, Elliott A, Sargatal J, Bierregaard R: Handbook of the birds of the world. Barcelona: Lynx Edicions; 1994.
46. Nowak Ronald M, Walker Ernest P: Walker's mammals of the world. 5th ed edn. Baltimore: Johns Hopkins University Press; 1991.
47. Corbet GB, Harris S, Mammal S: The handbook of British mammals. 3rd. ed. edn. Oxford: Blackwell Scientific; 1991.
48. Van Damme JME: Handbook of plant lectins : properties and biomedical applications. Chichester: John Wiley; 1998.
49. Sharon N, Lis H: Lectins. 2nd ed. edn. Dordrecht; London: Kluwer Academic Publishers; 2003.
50. Kolberg J, Wedege E, Sollid L: Immunoblotting detection of lectins in gluten and white rice flour. Biochem Biophys Res Commun 1987, 142:717-723.
51. Silano M, De Vincenzi M: Bioactive antinutritional peptides derived from cereal prolamins: a review. Nahrung 1999, 43:175-184.
52. Di Cagno R, De Angelis M, Lavermicocca P, De Vincenzi M, Giovannini C, Faccia M, Gobbetti M: Proteolysis by sourdough lactic acid bacteria: effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance. Appl Environ Microbiol 2002, 68:623-633.
53. Mercenier A, Pavan S, Pot B: Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 2003, 9:175-191.
54. Shewry PR, Halford NG: Cereal seed storage proteins: structures, próperties and role in grain utilization. J Exp Bot 2002, 53:947-958.
55. Minetti M, Aducci P, Teichner A: A new agglutinating activity from wheat flour inhibited by tryptophan. Biochim Biophys Acta 1976, 437:505-517.
56. Nachbar MS, Oppenheim JD: Lectins in the United States diet: a survey of lectins in commonly consumed foods and a review of the literature. Am J Clin Nutr 1980, 33:2338-2345.
57. Freed DLJ: Lectins in food: Their importance in health and disease. Journal of Nutritional Medicine 1991, 2:45-65.
58. Wang Q, Yu LG, Campbell BJ, Milton JD, Rhodes JM: Identification of intact peanut lectin in peripheral venous blood. Lancet 1998, 352:1831-1832.
59. Freed DL: Do dietary lectins cause disease? Bmj 1999, 318:1023-1024.
60. Wang XY, Bergdahl K, Heijbel A, Liljebris C, Bleasdale JE: Analysis of in vitro interactions of protein tyrosine phosphatase 1B with insulin receptors. Mol Cell Endocrinol 2001, 173:109-120.
61. Zeng FY, Benguria A, Kafert S, Andre S, Gabius HJ, Villalobo A: Differential response of the epidermal growth factor receptor tyrosine kinase activity to several plant and mammalian lectins. Mol Cell Biochem 1995, 142:117-124.
62. Ponzio G, Debant A, Contreres JO, Rossi B: Wheat-germ agglutinin mimics metabolic effects of insulin without increasing receptor autophosphorylation. Cell Signal 1990, 2:377-386.
63. Livingston JN, Purvis BJ: The effects of wheat germ agglutinin on the adipocyte insulin receptor. Biochim Biophys Acta 1981, 678:194-201.
64. Hedo JA, Harrison LC, Roth J: Binding of insulin receptors to lectins: evidence for common carbohydrate determinants on several membrane receptors. Biochemistry 1981, 20:3385-3393.
65. Fujii M, Sugamura K, Nakamura M, Ishii T, Hinuma Y: Selective inhibition of high- but not low-affinity interleukin 2 binding by lectins and anti-interleukin 2 receptor alpha antibody. Microbiol Immunol 1988, 32:857-867.
66. Kilpatrick DC: Mechanisms and assessment of lectin-mediated mitogenesis. Mol Biotechnol 1999, 11:55-65.
67. Ohmori T, Yatomi Y, Wu Y, Osada M, Satoh K, Ozaki Y: Wheat germ agglutinin-induced platelet activation via platelet endothelial cell adhesion molecule-1: involvement of rapid phospholipase C gamma 2 activation by Src family kinases. Biochemistry 2001, 40:12992-13001.
68. Banks WA, Ibrahimi F, Farr SA, Flood JF, Morley JE: Effects of wheatgerm agglutinin and aging on the regional brain uptake of HIV-1GP120. Life Sci 1999, 65:81-89.
69. Villegas JC, Broadwell RD: Transcytosis of protein through the mammalian cerebral epithelium and endothelium. II. Adsorptive transcytosis of WGA-HRP and the blood-brain and brain-blood barriers. J Neurocytol 1993, 22:67-80.
70. Mares V, Borges LF, Sidman RL: Uptake and transport of lectins from the cerebrospinal fluid by cells of the immature mouse brain. Acta Histochem 1984, 74:11-19.
71. Cordain L, Toohey L, Smith MJ, Hickey MS: Modulation of immune function by dietary lectins in rheumatoid arthritis. Br J Nutr 2000, 83:207-217.
72. Geleff S, Bock P: Pancreatic duct glands. II. Lectin binding affinities of ductular epithelium, ductular glands, and Brunner glands. Histochemistry 1984, 80:31-38.
73. Gabor F, Klausegger U, Wirth M: The interaction between wheat germ agglutinin and other plant lectins with prostate cancer cells Du-145. Int J Pharm 2001, 221:35-47.
74. Davis HR, Glagov S: Lectin binding to distinguish cell types in fixed atherosclerotic arteries. Atherosclerosis 1986, 61:193-203.
75. Kagami H, Uryu K, Okamoto K, Sakai H, Kaneda T, Sakanaka M: Differential lectin binding on walls of thoraco-cervical blood vessels and lymphatics in rats. Okajimas Folia Anat Jpn 1991, 68:161-170.
76. Tchernychev B, Wilchek M: Natural human antibodies to dietary lectins. FEBS Lett 1996, 397:139-142.
77. Shechter Y: Bound lectins that mimic insulin produce persistent insulin-like activities. Endocrinology 1983, 113:1921-1926.
78. Cuatrecasas P, Tell GP: Insulin-like activity of concanavalin A and wheat germ agglutinin--direct interactions with insulin receptors. Proc Natl Acad Sci U S A 1973, 70:485-489.
79. Damm I, Mikkat U, Kirchhoff F, Bockmann S, Jonas L: Inhibitory effect of the lectin wheat germ agglutinin on the binding of 1251-CCK-8s to the CCK-A and - B receptors of AR42J cells. Pancreas 2004, 28:31-37.
80. Lascols 0, Cherqui G, Munier A, Picard J, Capeau J: Differences in both glycosylation and binding properties between rat and mouse liver prolactin receptors. Cell Mol Biol (Noisy-le-grand) 1994, 40:359-371.
81. Chochola J, Fabre C, Bellan C, Luis J, Bourgerie S, Abadie B, Champion S, Marvaldi J, el Battari A: Structural and functional analysis of the human vasoactive intestinal peptide receptor glycosylation. Alteration of receptor function by wheat germ agglutinin. J Biol Chem 1993, 268:2312-2318.
82. Johnson RJ, Simpson S, Van Epps DE, Chenoweth DE: Wheat germ agglutinin inhibits the C5a receptor interaction: implications for receptor microheterogeneity and ligand binding site. J Leukoc Biol 1992, 52:3- 10.
83. Elliott S, Lorenzini T, Asher S, Aoki K, Brankow D, Buck L, Busse L, Chang D, Fuller J, Grant J, et al: Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat Biotechnol 2003, 21:414-421.
84. Lammert A, Brockmann G, Renne U, Kiess W, Bottner A, Thiery J, Kratzsch J: Different isoforms of the soluble leptin receptor in non-pregnant and pregnant mice. Biochem Biophys Res Commun 2002, 298:798-804.
85. Quinton ND, Lee AJ, Ross RJ, Eastell R, Blakemore AI: A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet 2001, 108:233-236.
86. Thompson DB, Ravussin E, Bennett PH, Bogardus C: Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet 1997, 6:675-679.
87. Stefan N, Vozarova B, Del Parigi A, Ossowski V, Thompson DB, Hanson RL, Ravussin E, Tataranni PA: The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism. Int J Obes Relat Metab Disord 2002, 26:1629-1632.
88. Chagnon YC, Chung WK, Perusse L, Chagnon M, Leibel RL, Bouchard C: Linkages and associations between the leptin receptor (LEPR) gene and human body composition in the Quebec Family Study. Int J Obes Relat Metab Disord 1999, 23:278-286.
89. Wauters M, Mertens I, Chagnon M, Rankinen T, Considine RV, Chagnon YC, Van Gaal LF, Bouchard C: Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int J Obes Relat Metab Disord 2001, 25:714-720.
90. Ukkola O, Tremblay A, Despres JP, Chagnon YC, Campfield LA, Bouchard C: Leptin receptor Gln223Arg variant is associated with a cluster of metabolic abnormalities in response to long-term overfeeding. J Intern Med 2000, 248:435-439.
91. Lakka TA, Rankinen T, Weisnagel SJ, Chagnon YC, Lakka HM, Ukkola O, Boule N, Rice T, Leon AS, Skinner JS, et al: Leptin and leptin receptor gene polymorphisms and changes in glucose homeostasis in response to regular exercise in nondiabetic individuals: the HERITAGE family study. Diabetes 2004, 53:1603-1608.
92. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART) [see comments]. Lancet 1989, 2:757-761.
93. Van Dam RM, Rimm EB, Willett WC, Stampfer MJ, Hu FB: Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med 2002, 136:201-209.
94. Koh-Banerjee P, Franz M, Sampson L, Liu S, Jacobs DR, Jr., Spiegelman D, Willett W, Rimm E: Changes in whole-grain, bran, and cereal fiber consumption in relation to 8-y weight gain among men. Am J Clin Nutr 2004, 80:1237-1245.
95. Wu Z, Bidlingmaier M, Liu C, De Souza EB, Tschop M, Morrison KM, Strasburger CJ: Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay. J Clin Endocrinol Metab 2002, 87:2931-2939.
96. Landt M, Horowitz JF, Coppack SW, Klein S: Effect of short-term fasting on free and bound leptin concentrations in lean and obese women. J Clin Endocrinol Metab 2001, 86:3768-3771.
97. Lindgarde F, Ercilla MB, Correa LR, Ahren B: Body adiposity, insulin, and leptin in subgroups of peruvian amerindians. High Alt Med Biol 2004, 5:27-31.
98. Lindgarde F, Widen I, Gebb M, Ahren B: Traditional versus agricultural lifestyle among Shuar women of the Ecuadorian Amazon: effects on leptin levels. Metabolism 2004, 53:1355-1358.
99. Magni P, Liuzzi A, Ruscica M, Dozio E, Ferrario S, Bussi I, Minocci A, Castagna A, . Motta M, Savia G: Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference. Clin Endocrinol (Oxf) 2005, 62:189-196.